BRIAN PHILLIPS: Open Payments
NPI 1326752221 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 29 payments from 13 companies in 2025. Trend: 2023 $125 · 2024 $96 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $148 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| Axsome Therapeutics, Inc. | 2 | $69 |
| Janssen Pharmaceuticals, Inc | 3 | $57 |
| E.R. Squibb & Sons, L.L.C. | 1 | $36 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Tris Pharma Inc | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| Indivior Inc. | 1 | $19 |
Products named: VRAYLAR, CAPLYTA, Auvelity, SPRAVATO, REXULTI, COBENFY, ABILIFY MAINTENA, INGREZZA.
Industry payments across IN — which companies pay providers there.
